Clinical Trial Google Ads: Policy Requirements and Compliant Campaign Setup
Google restricts clinical trial recruitment advertising, and most marketing teams find that out only after a campaign gets disapproved. Google's own Advertising Policies page for clinical trial recruitment states the rule, but it stops there. It doesn't explain how to build a campaign that clears review, targets patients who can actually reach a trial site, and survives IRB sign-off before launch. That gap costs CROs and sponsors real enrollment time. This guide covers both sides: what Google's clinical trial recruitment policy actually requires, and how to structure a geo-targeted, IRB-approved Google Ads campaign inside those limits.
What Google's clinical trial ads policy actually requires
Google restricts clinical trial recruitment promotion to a defined set of countries and advertiser types. Every claim in this section comes directly from Google's Advertising Policies page for clinical trial recruitment, not a secondhand summary. Prescription drug promotion is not allowed under this policy, and ads cannot create misleading expectations about the treatment being studied. The rules below reflect that page as written. Because Google updates policy pages without notice, confirm current wording before a campaign launches.
Where clinical trial ads are allowed
Clinical trial recruitment ads run only in the countries and regions Google's Advertising Policies page for clinical trial recruitment names as eligible (currently Australia, Belgium, Canada, China, France, Germany, Indonesia, Ireland, Israel, Italy, Japan, Korea, Malaysia, the Netherlands, New Zealand, the Philippines, Singapore, Taiwan, Thailand, the United Kingdom, the United States, and Vietnam), and that list is narrower than general healthcare advertising. Running a campaign outside an eligible location gets it rejected regardless of how well the ad is written, so confirm eligibility for every target market before building keywords or budgets.
Who can advertise, and what certification looks like
In eligible locations, some advertisers must apply for and receive Google's approval before their clinical trial recruitment ads can serve. Google's own policy page frames this as an application ("apply for healthcare-related advertising"), and a separate application is required for each location or group of locations an advertiser targets. That approval step sits on top of standard account setup, so build it into the campaign timeline rather than treat it as a formality. An advertiser who skips it will see ads disapproved even when every other element of the campaign is correct.
Why clinical trial Google Ads get disapproved
Once an advertiser is already eligible to run the campaign, most disapprovals trace back to landing page mismatch or restricted claim language, not the base recruitment restriction itself. Two patterns account for most rejections.
Google's Advertising Policies page for clinical trial recruitment states this directly: prescription drugs may not be promoted, and promotions may not create misleading expectations about the product being tested or imply that it is safe. Language that reads as recruiting for a cure rather than a study gets flagged during review.
The landing page also has to match what the ad says: same condition, same study, same claims. A mismatched landing page is a common and avoidable rejection reason: an ad that mentions a trial but lands on a general clinic homepage, or a page with eligibility language different from the ad's.
Geo-targeting around trial sites
A campaign built around a national or broad-state radius spends most of its budget on people who will never travel to an enrolling site. Radius targeting built around each site is the lever that makes clinical trial Google Ads efficient, because most patients only consider a trial within a realistic driving distance.
Condition and location keyword structure
Pair condition terms with the geography around each site rather than running one broad-match campaign nationwide. A patient in that market searches by pairing a condition with a location, such as a condition plus a city, or a condition plus "study near" a site. Keyword patterns should reflect that behavior. For example, a phase 3 dermatology trial in Florida narrows its keyword set to that condition paired with the city and county around the one enrolling site, not a statewide dermatology term. Teams building this alongside other acquisition work can pull broader acquisition-channel context beyond paid search into the same planning process.
Structuring multi-site campaigns
Build one ad group per site, or per tight geographic cluster of sites, rather than one campaign covering every location. That structure keeps keywords from competing against each other across sites and keeps spend attributable to the site it's recruiting for. That distinction matters when a sponsor wants to know which locations are underperforming. This connects to how a trial's on-the-ground recruitment operations are staffed and reported, though day-to-day site coordination sits outside what a paid-media campaign controls.
Landing page requirements for clinical trial ads
Google's policy requires the landing page to match the ad's claims and disclose the study clearly. Separately, most sponsors' own ethics review requires that same landing page copy to be pre-approved before the campaign can go live. Both requirements point to the same practical rule: write the page before the ad, not after.
The landing page needs to disclose eligibility criteria in plain language, the trial's phase and purpose, and the sponsor or CRO running the study. A page missing any of these is a common reason for both a policy disapproval and an IRB revision request.
IRB ad-approval and advertising law: what actually governs the copy
The compliance layer that actually controls clinical trial ad copy is IRB, or equivalent ethics committee, ad-approval, plus general FTC truth-in-advertising standards and applicable state advertising law. It is not HIPAA. HIPAA governs how covered entities handle protected health information, such as storing a form submission. It says nothing about how a recruitment ad is worded or targeted.
Recruitment materials, including the ad copy and the landing page, need IRB or ethics committee approval before they run on any channel, not just Google. Build that review time into the campaign timeline. Revisions and resubmissions can add weeks, and submitting several ad variations for approval at once avoids a fresh review cycle for every new headline later.
The FTC's truth-in-advertising standard requires that any claim in the ad or landing page be substantiated, meaning there is evidence behind it before it runs, not after a complaint arrives.
Some states carry their own advertising rules that can affect language around compensation disclosure for trial participants. Treat this as a jurisdiction-specific check rather than a single national rule, and confirm the applicable state's requirements for the markets a campaign targets.
HIPAA is mentioned here only to draw that boundary. It is never the standard that makes a clinical trial ad compliant, and describing an ad as "HIPAA compliant" misstates what actually governs it.
What clinical trial recruitment costs on Google Ads
Cost per lead on clinical trial Google Ads campaigns varies widely by condition and site geography, and there is no universal benchmark. A properly geo-targeted, IRB-approved campaign performs meaningfully better than a broad, unoptimized one built around vague national targeting.
As one real-world example, Brighter Click's clinical trial recruitment work restructured a CRO's Google Ads program around geo-targeted, site-level campaigns. Managed spend grew from $360K to $600K per month, cost per lead dropped 45.9% into a $20 to $39 range, and click-to-conversion rate rose 91.5%. Treat this as one CRO's result under its own conditions, not a market rate to expect on day one.
Running a compliant campaign without an in-house team
Most CROs and sponsors don't have in-house Google Ads certification or ongoing policy expertise, and that gap is a practical reason many trials under-enroll on paid search even when budget exists.
Recruitment software that screens and matches leads is a useful complement to paid media, not a substitute for it. The software still needs qualified traffic reaching it, which is what a compliant, geo-targeted campaign supplies.
Brighter Click is best for clinical trial patient recruitment through geo-targeted, IRB-approved paid media built for CROs and healthtech brands. The agency handles the advertiser approval process, policy review, site-level campaign structure, and IRB coordination as one workflow instead of three separate hires.
Talk to an agency that's helped meet recruitment targets through paid media
Brighter Click builds geo-targeted, IRB-approved Google Ads campaigns for CROs and sponsors running clinical trial recruitment, the same approach behind the spend and CPL numbers above.
Frequently asked questions about clinical trial Google adsaw
What is Google's policy on clinical trial recruitment ads?
Google restricts clinical trial recruitment advertising. It's allowed only in certain locations, and in some of those, only for advertisers approved under Google's healthcare policies. Prescription drugs cannot be promoted, and ads cannot create misleading expectations about the treatment being tested. The exact country list and application rules live on Google's Advertising Policies page for clinical trial recruitment, which is the only authoritative source. Check it before every launch, since Google updates policy pages without notice.
Do clinical trial ads need IRB approval before they run?
Yes. Recruitment materials, including ad copy and the landing page, must be approved by the trial's IRB or ethics committee before they run on every channel, not just Google. Build that review time into your launch plan, since revisions and resubmissions can add weeks. Submitting several ad variations for review at once lets you test later without a fresh approval cycle for every new headline.
How much does clinical trial recruitment cost on Google Ads?
There's no universal benchmark. Cost per lead depends on the condition, keyword competition, and how tightly campaigns are geo-targeted around enrolling sites. Broad campaigns waste spend on people too far from a site to enroll. As one directional example, Brighter Click's clinical trial recruitment work for a CRO produced cost per lead in the $20 to $39 range after restructuring, a 45.9% decrease. Treat any published figure as one trial's result, not a market rate.
Do clinical trial Google Ads need to be HIPAA compliant?
No, and this is a common mix-up. HIPAA governs how covered entities handle protected health information, such as storing a form submission. It doesn't govern ad copy, targeting, or creative. What actually controls the ad is Google's clinical trial recruitment policy, IRB approval of the recruitment materials, and FTC truth-in-advertising standards, plus applicable state advertising rules. Handle the data your landing page collects carefully, but don't describe the ad itself as HIPAA compliant. That isn't what makes it lawful.
How do you track patient enrollment from Google Ads?
Track it in two layers. First, use Google Ads conversion tracking to tie clicks to pre-screener or contact form completions. Second, match those leads to actual enrollment in your CRM or recruitment platform, so you're reporting cost per enrolled patient rather than cost per click. Click metrics alone mislead in this space, since many form fills never pass screening. Review lead-to-enrollment data regularly and shift budget toward the campaigns and sites that actually enroll.
How many clinical trials fail to recruit enough patients?
A large share of trials miss their original enrollment timelines, which is part of why sponsors turn to paid channels like Google Ads at all. Peer-reviewed analyses indexed on NIH's PubMed Central document widespread enrollment delays and under-enrollment across trial phases. Exact figures vary by study and therapeutic area, so a specific published analysis should be cited rather than a rounded statistic. The practical takeaway: recruitment risk is the norm, and it justifies planning paid recruitment early.
How should condition-specific trial ads, like oncology, be structured?
Pair condition terms with geography. Keywords like a condition plus a city, or a condition plus "study near" a site, match how patients actually search. One ad group per site keeps spend attributable. Sensitive conditions such as oncology need extra care in the copy: no efficacy promises, plain eligibility language, and wording the IRB has already approved. The keyword architecture stays the same for Alzheimer's, dermatology, or any other area; what changes is the sensitivity of the language and the screening questions.
Do you need a specialized agency to run clinical trial Google Ads?
Not strictly, but most CROs and sponsors lack in-house Google Ads policy expertise, and that gap is a common reason trials under-enroll on paid search even when budget exists. A specialized partner handles the advertiser approval process, policy review, geo-targeted campaign structure, and IRB coordination as one workflow. If you keep it in-house, assign a clear owner for policy compliance and enrollment tracking, not just campaign management.
